http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CR-20130629-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44c259969d1e77db2c3b7641223e312f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bd65767374a838b4b8b888648875e21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acda2d3c1bf52d8792466e3cc6c4379b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b66a9189b600c2096923811d344d71b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4117e71c4c94db246bc66405c55fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bb5323694d8bf6a6c1960edd10febc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025deebff8d0fc4616c24bd70ef5d516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bfae1df6cb2a76ae984d47470f8143b
publicationDate 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CR-20130629-A
titleOfInvention COMPOUNDS OF 2- (2,4,5-REPLACED ANILINO) PYRIMIDINE
abstract The present invention relates to certain 2- (2,4,5-substituted anilino) pyrimidine compounds and pharmaceutically acceptable salts thereof that may be useful in the treatment or prevention of a medical disease or condition mediated by certain mutated forms of epidermal growth factor receptor (for example the activating mutant L858R.
priorityDate 2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571425
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395511
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463415
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24329
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13649
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404306
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04412

Total number of triples: 46.